Treatment options for sickle cell disease and other childhood blood disorders have improved dramatically in the last decade. Much of that is due to clinical trials and other research. Washington University researchers at St. Louis Children’s Hospital are leaders in developing new therapies for children.
Research for Blood Disorders
Our team of Washington University physicians continuously looks for new ways to help children with blood disorders through clinical trials for sickle cell disease, lymphoma and other conditions.
We participate in clinical trials through the National Institutes of Health (NIH), Children's Oncology Group and in studies sponsored by drug companies.
For instance, we know silent strokes — strokes that do not have outward symptoms — are more common in children with blood disorders. These strokes can cause problems with memory, school and learning. We are looking at blood flow patterns in these patients in the hopes of finding new treatments for the future.
Search for a Pediatric Blood Disorder Clinical Trial
Search for active clinical trials at clinicaltrials.gov. You can:
- Search by "studies on map"
- Click on “Missouri”
- Look for studies with “Washington University School of Medicine" or "St. Louis Children’s Hospital” as participating locations
To learn more, call St. Louis Children's Hospital at 314.454.5437.
